 |
|
Graves Ophthalmopathy and Mood Disturbance—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We appreciate the interest of Dr Yuen and colleagues in our study of mood disturbance in patients with GO. We agree that the relatively high prevalence of antidepressant use in the patients who completed our survey only serves to confirm our conclusions about the mood disturbance in this population of patients. Considering that antidepressant use was an exclusion criterion for the analysis, our study actually underestimates the extent of these disturbances. This further underscores the importance of recognizing the emotional consequences of GO when managing these patients.
With regard to the indications for surgery in the control group, the surgical indications for both groups were similar. As Dr Yuen and colleagues pointed out, 58% of the patients in the study group had previous orbital, eyelid, or muscle surgery compared with 50% of the control group. Our study looked at a moment in time: regardless of the previous severity . . . [Full Text of this Article]
AUTHOR INFORMATION
Marjan Farid, MD;
Anne-Catherine Roch-Levecq, PhD;
Leah Levi, MBBS;
Barbara Brody, MPH;
David B. Granet, MD;
Don O. Kikkawa, MD
RELATED LETTER
Graves Ophthalmopathy and Mood Disturbance
Kenneth S. C. Yuen, Arthur C. K. Cheng, and Wai-Man Chan
Arch Ophthalmol. 2006;124(3):426-427.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Psychological Disturbance in Graves Ophthalmopathy
Marjan Farid, Anne-Catherine Roch-Levecq, Leah Levi, Barbara L. Brody, David B. Granet, and Don O. Kikkawa
Arch Ophthalmol. 2005;123(4):491-496.
ABSTRACT
| FULL TEXT
|
